GlassScriptPhysician profile
Douglas A Murrey
NPI 1649470170
$70,284.37
in general payments reported to CMS, 2019-2025
28 companies · $6,367 in 2025
The $6,367 reported for 2025 was more than what 87% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $13K · 2021: $21K · 2022: $6,741 · 2023: $1,212 · 2024: $8,971 · 2025: $6,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $2,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,975.00 |
| Food and Beverage | $2,575.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $65,030.06 | 2019-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Inari Medical, INC. | $1,230.09 | 2019-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $707.86 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $607.88 | 2019-2023 | Rotarexs 6 F X 135 Cm |
| Janssen Pharmaceuticals, INC | $305.47 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $289.50 | 2019-2025 | Ekosonic |
| Abbott Laboratories | $264.33 | 2021-2024 | Jeti Peripheral Catheter |
| Terumo Medical Corporation | $220.55 | 2019-2021 | |
| Philips North America LLC | $217.87 | 2019 | |
| Shockwave Medical, INC | $206.28 | 2019-2021 | |
| Ge Healthcare | $176.67 | 2022 | |
| Angiodynamics, INC. | $175.00 | 2021 | |
| Exelixis INC. | $134.60 | 2019 | |
| Telix Pharmaceuticals | $125.00 | 2024 | Illuccix |
| Progenics Pharmaceuticals, INC. | $125.00 | 2023 | Pylarify |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dova Pharmaceuticals | $115.00 | 2019 | |
| Penumbra, INC. | $74.86 | 2019-2021 | |
| Medtronic USA, INC. | $68.65 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.46 | 2025 | |
| Pfizer INC. | $32.33 | 2025 | |
| Medtronic, INC. | $26.52 | 2021 | |
| Avenu Medical INC. | $24.20 | 2020 | |
| Endologix LLC | $20.67 | 2021 | |
| Argon Medical Devices, INC. | $20.47 | 2025 | Clot Management |
| Cook Medical LLC | $19.50 | 2019 | |
| Ekos Corporation | $17.40 | 2019 | |
| Merit Medical Systems INC | $8.15 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Murrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.